Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ALNY
|
Sanofi
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 344,448 Added 3.64% |
$23,036,681
$66.88 p/Share
|
Mar 25
2014 |
|
ORCL
|
Dorian Daley
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 95.24% |
$3,827,000
$38.27 p/Share
|
Mar 25
2014 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Indirect | 2,445 Reduced 2.16% |
$45,232
$18.5 p/Share
|
Mar 25
2014 |
|
ADBE
|
John E Warnock
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 75.66% |
$3,281,000
$65.62 p/Share
|
Mar 24
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 306,945 Added 0.1% |
$94,140,035
$306.7 p/Share
|
Mar 24
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 305,115 Added 0.08% |
$98,472,812
$322.74 p/Share
|
Mar 21
2014 |
|
NVDA
|
Ajay K Puri
EVP, Worldwide Field Ops |
BUY
Open market or private purchase
|
Direct | 114 Added 0.02% |
$2,147
$18.83 p/Share
|
Mar 21
2014 |
|
ORCL
|
Jeffrey Henley
Vice Chairman |
SELL
Open market or private sale
|
Direct | 750,000 Reduced 100.0% |
$28,694,999
$38.26 p/Share
|
Mar 21
2014 |
|
NVDA
|
Debora Shoquist
EVP, Operations |
SELL
Open market or private sale
|
Direct | 8,085 Reduced 4.16% |
$149,815
$18.53 p/Share
|
Mar 20
2014 |
|
ADBE
|
James E Daley
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 24.89% |
$345,000
$69.0 p/Share
|
Mar 20
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 57,957 Added 0.08% |
$18,993,668
$327.72 p/Share
|
Mar 20
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 9,746 Added 0.02% |
$3,192,497
$327.57 p/Share
|
Mar 19
2014 |
|
SPOK
|
Matthew Oristano
Director |
SELL
Open market or private sale
|
Direct | 2,476 Reduced 15.4% |
$42,067
$16.99 p/Share
|
Mar 19
2014 |
|
LOW
|
Robert A Niblock
Chairman President & CEO |
SELL
Open market or private sale
|
Direct | 24,996 Reduced 4.41% |
$1,238,552
$49.55 p/Share
|
Mar 18
2014 |
|
NVDA
|
David M Shannon
EVP, CAO & Secretary |
SELL
Open market or private sale
|
Indirect | 2,446 Reduced 2.16% |
$44,273
$18.1 p/Share
|
Mar 18
2014 |
|
LOW
|
Ricky D Damron
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 67,949 Reduced 39.64% |
$3,379,783
$49.74 p/Share
|
Mar 18
2014 |
|
AMT
|
Raymond P Dolan |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 52.47% |
$820,000
$82.0 p/Share
|
Mar 18
2014 |
|
SPB
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Indirect | 23,000,000 Added 35.59% |
$253,000,000
$11.0 p/Share
|
Mar 18
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 60,128 Added 0.17% |
$19,757,459
$328.59 p/Share
|
Mar 17
2014 |
|
V
|
Alfred F Kelly Jr
EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Direct | 1,575 Added 50.0% |
$350,752
$222.7 p/Share
|
Mar 17
2014 |
|
NCLH
|
Robert Becker
Senior Vice President |
SELL
Open market or private sale
|
Direct | 27,500 Reduced 100.0% |
$878,625
$31.95 p/Share
|
Mar 17
2014 |
|
URI
|
Jenne K Britell
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 4.03% |
$200,244
$91.02 p/Share
|
Mar 17
2014 |
|
URI
|
Singleton B Mcallister
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 12.78% |
$275,370
$91.79 p/Share
|
Mar 17
2014 |
|
ORCL
|
Hector Garcia Molina
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 33.33% |
$94,600
$37.84 p/Share
|
Mar 17
2014 |
|
NEE
|
William L Yeager
EVP Eng, Const. & ISC |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 31.6% |
$379,360
$94.84 p/Share
|
Mar 17
2014 |
|
LOW
|
Robert A Niblock
Chairman President & CEO |
SELL
Open market or private sale
|
Direct | 55,576 Reduced 8.93% |
$2,755,458
$49.58 p/Share
|
Mar 17
2014 |
|
URI
|
Dale A Asplund
EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 15.58% |
$546,000
$91.0 p/Share
|
Mar 14
2014 |
|
COST
|
John D Mc Kay
Executive Vice President |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 4.35% |
$342,000
$114.0 p/Share
|
Mar 14
2014 |
|
JNJ
|
Peter Fasolo
Exec VP, Chief HR Officer |
SELL
Open market or private sale
|
Direct | 6,824 Reduced 30.37% |
$635,656
$93.15 p/Share
|
Mar 14
2014 |
|
COST
|
Richard A Galanti
Executive Vice President |
SELL
Open market or private sale
|
Direct | 15,164 Reduced 23.21% |
$1,738,553
$114.65 p/Share
|
Mar 14
2014 |
|
COST
|
James D Sinegal
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 0.44% |
$456,000
$114.0 p/Share
|
Mar 14
2014 |
|
COST
|
W Craig Jelinek
Director |
SELL
Open market or private sale
|
Direct | 41,444 Reduced 14.87% |
$4,725,031
$114.01 p/Share
|
Mar 14
2014 |
|
EVRI
|
Juliet Lim
EVP |
BUY
Open market or private purchase
|
Direct | 5,000 Added 50.0% |
$40,500
$8.1 p/Share
|
Mar 14
2014 |
|
EVRI
|
Randy L Taylor
President & CEO |
BUY
Open market or private purchase
|
Direct | 5,000 Added 32.15% |
$40,500
$8.1 p/Share
|
Mar 14
2014 |
|
EVRI
|
Ram Chary
President & CEO |
BUY
Open market or private purchase
|
Direct | 15,000 Added 50.0% |
$121,050
$8.07 p/Share
|
Mar 14
2014 |
|
EVRI
|
Michael Scott Dowty
EVP |
BUY
Open market or private purchase
|
Direct | 10,000 Added 24.01% |
$80,600
$8.06 p/Share
|
Mar 14
2014 |
|
EVRI
|
Robert Myhre
EVP |
BUY
Open market or private purchase
|
Direct | 5,000 Added 10.59% |
$40,350
$8.07 p/Share
|
Mar 14
2014 |
|
EVRI
|
E Miles Kilburn
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 7.48% |
$81,100
$8.11 p/Share
|
Mar 14
2014 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 55,583 Added 0.08% |
$18,230,113
$327.98 p/Share
|
Mar 14
2014 |
|
EVRI
|
David Lucchese
EVP, Sales and Marketing |
BUY
Open market or private purchase
|
Direct | 5,000 Added 6.05% |
$41,100
$8.22 p/Share
|
Mar 14
2014 |
|
NP
|
John F Mcgovern
Director |
SELL
Open market or private sale
|
Direct | 9,169 Reduced 100.0% |
$452,674
$49.37 p/Share
|
Mar 13
2014 |
|
URI
|
John S Mckinney
Director |
SELL
Open market or private sale
|
Direct | 4,900 Reduced 36.38% |
$451,878
$92.22 p/Share
|
Mar 13
2014 |
|
URI
|
Pierre E Leroy
Director |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 64.75% |
$1,366,950
$91.13 p/Share
|
Mar 13
2014 |
|
PEP
|
Cynthia Trudell
EVP, HR & Chief HR Officer |
SELL
Open market or private sale
|
Direct | 57,098 Reduced 47.55% |
$4,687,175
$82.09 p/Share
|
Mar 13
2014 |
|
COST
|
Timothy L. Rose
Executive VP |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 12.03% |
$576,550
$115.31 p/Share
|
Mar 12
2014 |
|
FHN
|
William C Losch Iii
Sr. EVP and CFO |
SELL
Open market or private sale
|
Direct | 11,550 Reduced 6.78% |
$139,408
$12.07 p/Share
|
Mar 12
2014 |
|
FHN
|
Charles T Tuggle Jr
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 12,100 Reduced 6.58% |
$144,837
$11.97 p/Share
|
Mar 12
2014 |
|
NP
|
John P O'Donnell
President and CEO |
SELL
Open market or private sale
|
Direct | 5,734 Reduced 100.0% |
$284,349
$49.59 p/Share
|
Mar 12
2014 |
|
INTU
|
Edward A Kangas
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$806,800
$80.68 p/Share
|
Mar 12
2014 |
|
NP
|
John F Mcgovern
Director |
SELL
Open market or private sale
|
Direct | 6,891 Reduced 100.0% |
$340,415
$49.4 p/Share
|
Mar 12
2014 |